Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 CHF | -2.86% | +0.29% | -1.16% |
Business Summary
Number of employees: 168
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 190 | 100.0 % | 7 | 100.0 % | -96.29% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 180 | 94.9 % | 7 | 100.0 % | -96.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 04-11-22 | |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Michael Pitzner
CMP | Compliance Officer | - | 22-10-31 |
Chief Operating Officer | - | 22-06-30 | |
Philippe Legenne
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Daniel Steiner
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Baris Arican
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Seth D. Lewis
IRC | Investor Relations Contact | - | 19-10-31 |
Renate Gloggner
HRO | Human Resources Officer | - | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 17-10-30 |
Steven Holtzman
BRD | Director/Board Member | 70 | 14-09-18 |
Vito Palombella
BRD | Director/Board Member | 61 | 20-03-31 |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Director/Board Member | 47 | 21-04-20 | |
Director/Board Member | 61 | 20-04-28 | |
Director/Board Member | 54 | 20-03-31 | |
Dominik Höchli
BRD | Director/Board Member | 57 | 21-04-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,682,086 | 29,810,270 ( 81.27 %) | 3,500,000 ( 9.541 %) | 81.27 % |
Company contact information
Sector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.16% | 125M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MOLN Stock
- Company Molecular Partners AG